Mixing of COVID Vaccines COVISHEILD and COVAXIN is Safe and elicits robust antibody response, says AIG Hospitals’ Study. This is the first pilot study from India analyzing COVAXIN – COVISHEILD
Bharat Biotech’s COVAXIN® authorized for emergency use by the World Health Organization. The WHO’s Emergency Use Listing (EUL) for COVAXIN® facilitates countries to expedite their regulatory approval processes to introduce
COVID-19 vaccination drive in India has been started. India has successfully administered the first jab of vaccine to lakhs of frontline workers. Two made-in-India vaccines, Covishield and Covaxin were administered